{"companyId":272701,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"Alpha Cognition Inc.","headOfficeLocation":"1452 Hughes Street, Suite 200, Grapevine, TX 76051, United States","presidentName":"Michael McFadden","companySummary":null,"stockCode":"ACOG","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["alphacognition.com"],"businessContents":["Commercial-stage biopharmaceutical company developing treatments for neurodegenerative diseases.","Markets ZUNVEYL (benzgalantamine) for mild to moderate Alzheimer's disease dementia."],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.alphacognition.com/","scoreAbout":500,"scoreBusiness":300,"scoreGroup":0,"scoreCustomer":0}]}